RxDoctor Payments Data

Ashwin Gowda, MD

Sleep Medicine · Austin, TXNPI 1669447397

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $48,885 of the $70,856 with a category attached, or 69.0%. 17 manufacturers reported payments, led by Lilly USA, LLC at 58.5% of the total. 2025 is the largest year on record at $43,719, more than ten times the $654 reported in 2019. Among sleep medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$70,856in general payments, 2019–2025

Across 306 payments — averaging $231.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$41K
  • Axsome Therapeutics, Inc.$11K
  • Jazz Pharmaceuticals Inc.$10K
  • Inspire Medical Systems, Inc.$5K
  • ZOLL Respicardia, Inc.$2K
  • Avadel CNS Pharmaceuticals, LLC$360
  • plus $1K from 11 others

What the payments were for

  • Consulting fees$8,37012%
  • Speaking & faculty fees$48,88569%
  • Travel & lodging$4,9167%
  • Food & beverage$8,36912%
  • Education$3160%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$70,856 in reported general payments places this provider in the 90th percentile of 112 sleep medicine providers in Texas.

See all sleep medicine providers in Texas

Medicare billing

Part B allowed, 2024
$252,749
Medicare patients
779
Services billed
1,619

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lisdexamfetamine Dimesylate11$2,357
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine28$821
Methylphenidate Hcl14$387
Trazodone Hcl24$283
Methadone Hcl11$93
Zolpidem Tartrate15$12

Paid to pharmacies, not to this prescriber.

Other sleep medicine in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →